Design, synthesis, and antiviral activity evaluation of phenanthrene-based antofine derivatives. 2012

Ziwen Wang, and Peng Wei, and Xu Xizhi, and Yuxiu Liu, and Lizhong Wang, and Qingmin Wang
State Key Laboratory of Elemento-Organic Chemistry, Research Institute of Elemento-Organic Chemistry, Nankai University , Tianjin 300071, People's Republic of China.

On the basis of our previous structure-activity relationship (SAR) and antiviral mechanism studies, a series of phenanthrene-based antofine derivatives (1-12 and 18-50) were designed targeting tobacco mosaic virus (TMV) RNA and synthesized and systematically evaluated for their antiviral activity against TMV. The bioassay results showed that most of these compounds exhibited good to excellent in vivo anti-TMV activity, of which compounds 19 and 27 displayed higher activity than commercial Ribavirin, thus emerging as potential inhibitors of plant virus. The novel concise structure provides another new template for antiviral studies.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D010616 Phenanthrenes POLYCYCLIC AROMATIC HYDROCARBONS composed of three fused BENZENE rings.
D010618 Phenanthrolines Phenanthroline
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012254 Ribavirin A nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses. Ribovirin,Tribavirin,ICN-1229,Rebetol,Ribamide,Ribamidil,Ribamidyl,Ribasphere,Vilona,Viramide,Virazide,Virazole,ICN 1229,ICN1229
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014027 Tobacco Mosaic Virus The type species of TOBAMOVIRUS which causes mosaic disease of NICOTIANA. Transmission occurs by mechanical inoculation. Mosaic Virus, Tobacco,Mosaic Viruses, Tobacco,Tobacco Mosaic Viruses,Virus, Tobacco Mosaic,Viruses, Tobacco Mosaic
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Ziwen Wang, and Peng Wei, and Xu Xizhi, and Yuxiu Liu, and Lizhong Wang, and Qingmin Wang
December 2010, Journal of agricultural and food chemistry,
Ziwen Wang, and Peng Wei, and Xu Xizhi, and Yuxiu Liu, and Lizhong Wang, and Qingmin Wang
August 2013, International journal of molecular sciences,
Ziwen Wang, and Peng Wei, and Xu Xizhi, and Yuxiu Liu, and Lizhong Wang, and Qingmin Wang
March 2023, Pharmaceuticals (Basel, Switzerland),
Ziwen Wang, and Peng Wei, and Xu Xizhi, and Yuxiu Liu, and Lizhong Wang, and Qingmin Wang
September 1994, Journal of medicinal chemistry,
Ziwen Wang, and Peng Wei, and Xu Xizhi, and Yuxiu Liu, and Lizhong Wang, and Qingmin Wang
February 2013, Bioorganic & medicinal chemistry,
Ziwen Wang, and Peng Wei, and Xu Xizhi, and Yuxiu Liu, and Lizhong Wang, and Qingmin Wang
February 2024, Chemistry & biodiversity,
Ziwen Wang, and Peng Wei, and Xu Xizhi, and Yuxiu Liu, and Lizhong Wang, and Qingmin Wang
July 2018, Bioorganic & medicinal chemistry,
Ziwen Wang, and Peng Wei, and Xu Xizhi, and Yuxiu Liu, and Lizhong Wang, and Qingmin Wang
June 1968, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Ziwen Wang, and Peng Wei, and Xu Xizhi, and Yuxiu Liu, and Lizhong Wang, and Qingmin Wang
April 2017, European journal of medicinal chemistry,
Ziwen Wang, and Peng Wei, and Xu Xizhi, and Yuxiu Liu, and Lizhong Wang, and Qingmin Wang
January 2007, Nucleosides, nucleotides & nucleic acids,
Copied contents to your clipboard!